Presse medicale (Paris, France : 1983) · 2000
[Cutaneous metastases from follicular thyroid cancer].
Клинический случайАннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cariou B, Charbonnel B, Heymann M F, Bridji B
Аннотация
BACKGROUND: Cutaneous metastases from differentiated thyroid carcinoma are rare: only 41 cases have been reported in the literature.
CASE REPORT: A 57-year-old woman underwent total thyroidectomy for a poor differentiated follicular thyroid carcinoma, with involvement of sternum and pulmonary metastases. Despite iodine-131 ablative therapy (> 1 Ci) she developed a skin metastasis of the scalp 9 years after the initial surgery. She died of widely metastatic thyroid carcinoma.
DISCUSSION: Follicular carcinoma has a greater preponderance than papillary carcinoma for cutaneous metastases. The majority of skin metastases are localized to the head and neck. The development of a cutaneous metastasis is commonly associated with metastasis to other distant tissues and is followed by a deteriorating course and eventual death resulting from malignancy.
CASE REPORT: A 57-year-old woman underwent total thyroidectomy for a poor differentiated follicular thyroid carcinoma, with involvement of sternum and pulmonary metastases. Despite iodine-131 ablative therapy (> 1 Ci) she developed a skin metastasis of the scalp 9 years after the initial surgery. She died of widely metastatic thyroid carcinoma.
DISCUSSION: Follicular carcinoma has a greater preponderance than papillary carcinoma for cutaneous metastases. The majority of skin metastases are localized to the head and neck. The development of a cutaneous metastasis is commonly associated with metastasis to other distant tissues and is followed by a deteriorating course and eventual death resulting from malignancy.